Mor Research Applications Ltd.

Curetech Ltd.

Tel Aviv University

Other

Annat Raiter

Britta Hardy

Leah Klapper

Alexander Battler

Chana Weiss

Ran Kornowski

An isolated peptide comprising an amino acid sequence HWRR as set forth by SEQ ID NO:5, the peptide consists of 4 or 5 amino acids, is provided. Also provided are methods of treating angiogenesis-related pathologies using the peptide of the invention or pharmaceutical compositions comprising same.

Compositions and methods for inducing angiogenesis

The present invention provides peptides and polynucleotides, and their use for immunomodulation, immunotherapy and vaccine particularly for anti-cancer therapy, and for diagnosis purposes. The immunomodulatory effect includes induction of proliferation and activation of peripheral blood lymphocytes and induction of an anti-tumor effect upon administration of peptides of the invention to subjects suffering from cancer.

Peptide useful in immunomodulation

A peptide comprising an amino acid sequence as set forth in SEQ ID NO: 2, 4, 6, 8, 10 or 12 is provided. The peptide being at least 6 and no more than 50 amino acid residues in length. Also provided are therapeutic applications using such peptides.

Angiogenic peptides and uses thereof

Growing community of inventors

Kfar Saba, Israel

Annat Raiter